Research on ereythropoietin and its receptor in anemia of neoplasm / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 231-233, 2008.
Article
in Chinese
| WPRIM
| ID: wpr-472806
ABSTRACT
The anemia of chronic disease is chronic infection, inflammation, a class of cancer-related anemia syndrome, anemia in patients with malignant tumors often. In recent years recombinant human erythropoietin, widely used in clinical treatment of anemia, Especially in cancer-related anemia treatment achieved remarkable results, a blood transfusion to avoid the many adverse effects and improve the patient' s quality of life. A control chemotherapy-induced anemia is an important choice. Therefore, rhEPO on cancer-related anemia treatment mechanism has also become a research hotspot.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS